AN2 Therapeutics, Inc. (ANTX)
Market Closed
16 Oct, 08:00 PM
NASDAQ (NGS) NASDAQ (NGS) Primary 
XHAM $
3. 38
-0.22
-6.1111%
$
158.47M Market Cap
- P/E Ratio
- Div Yield
281,700 Volume
- Eps
$ 3.6
Previous Close Want to track ANTX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
AN2 Therapeutics, Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| CD Charlie Durham Sterling Capital Management LLC | 484 | $2,516.8 | $1,713.36 | -$803.44 | -31.92% |
 Joseph Castro Nuveen LLC | 35,333 | $183,731.6 | $125,078.82 | -$58,652.78 | -31.92% |
 Drew Phillips Fortitude Family Office LLC | 90 | $479 | $324 | -$155 | -32.36% |
 Hui Fai Tam Caitong International Asset Management Co. Ltd. | 274 | $937.08 | $986.4 | $49.32 | 5.26% |
 Mark Schafer Police & Firemen's Retirement System of New Jersey | 8,615 | $44,798 | $30,497.1 | -$14,300.9 | -31.92% |
 SummitTX Capital LP SummitTX Capital LP | 597,453 | $3.11M | $2M | -$1.11M | -35.58% |
2026 © Marketlog. All Rights Reserved.
